Laddar populära aktier...
Innofactor’s Q2 profitability was weak, although mostly due to one-offs.
Consti's net sales in Q2 amounted to EUR 82.9m, above our estimates (Evli est.
- Return to growth in Q2 bodes well for 9-10% organic growth in H2e - AI and cybersecurity among the...
Redeye comments on Annexin's Q2 report and recent events in the company.
Redeye sees a soft quarter from CombinedX, with slightly lower sales and substantially lower margins...
Redeye believes Sdiptech's Q2 report was solid, with continued good organic sales growth in both bus...
Redeye thinks the Q2 report was slightly better than expected - being in line with consensus estimat...
Redeye’s first take on the Q2 report this morning. Despite some underlying differences, Cellavision ...
- Rec. PTP +9% vs. ABGSCe - Value changes positive, first time since Q4'22 - Earnings capacity IFPM ...
Redeye believes the major design win announced in the Q2 report sets Sivers' 5G potential in a whole...
Redeye provides a research update following the Q2 report recently published by Magle.
Redeye updates its estimates and valuation following ADDvise releasing its Q2 2024 report, which fea...
Atria's Q2 EBIT beat LSEG Data & Analytics consensus clearly.
Redeye makes minor revisions based on the Q2 report.
- We raise '24e-'26e adj. EBIT by 3-1% - Conducive conditions for organic growth - Trading at NTM EV...